Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
MENON ANIL,LEE THOMAS,BOERSEN NATHAN,ECKERT JEFFREY,PARIKH DARSHAN K.
申请号:
NZ62987714
公开号:
NZ629877A
申请日:
2014.09.03
申请国别(地区):
NZ
年份:
2015
代理人:
摘要:
Disclosed are crystal and amorphous forms of 1-Ethyl-7-(2-Methyl-6-(1H-1,2,4-Triazol-3-yl)Pyridin-3-yl)-3,4-Dihydropyrazino[2,3-B]Pyrazin-2(1H)-One. The solid forms of the Compound are useful for treating or preventing cancer and conditions treatable or preventable by inhibition of a kinase pathway, for example, the mTOR/PI3K/Akt pathway.